Lineage Cell (Israel) Analysis
| BTX Stock | ILS 195.00 33.90 14.81% |
Lineage Cell Therapeutics is overvalued with Real Value of 206.18 and Hype Value of 228.9. The main objective of Lineage Cell stock analysis is to determine its intrinsic value, which is an estimate of what Lineage Cell Therapeutics is worth, separate from its market price. There are two main types of Lineage Cell's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Lineage Cell's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Lineage Cell's stock to identify patterns and trends that may indicate its future price movements.
The Lineage Cell stock is traded in Israel on Tel Aviv Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Sun except for officially observed holidays in Israel. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Lineage Cell's ongoing operational relationships across important fundamental and technical indicators.
Lineage |
Lineage Stock Analysis Notes
The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Lineage Cell Therapeutics had not issued any dividends in recent years. BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California. BIOTIME INC operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 76 people. For more info on Lineage Cell Therapeutics please contact the company at 510-521-3390 or go to http://www.biotimeinc.com.Lineage Cell Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Lineage Cell's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Lineage Cell Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Lineage Cell generated a negative expected return over the last 90 days | |
| Lineage Cell has high historical volatility and very poor performance | |
| The company reported the revenue of 4.99 M. Net Loss for the year was (45.99 M) with profit before overhead, payroll, taxes, and interest of 4.69 M. | |
| Lineage Cell Therapeutics has accumulated about 27.1 M in cash with (30.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. |
Lineage Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 512.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lineage Cell's market, we take the total number of its shares issued and multiply it by Lineage Cell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 3rd of March, Lineage Cell secures the Risk Adjusted Performance of (0.03), mean deviation of 4.55, and Standard Deviation of 6.38. Lineage Cell Therapeutics technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.Lineage Cell Therapeutics Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Lineage Cell middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Lineage Cell Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Lineage Cell Predictive Daily Indicators
Lineage Cell intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Lineage Cell stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 8941.1 | |||
| Daily Balance Of Power | (1.43) | |||
| Rate Of Daily Change | 0.85 | |||
| Day Median Price | 202.15 | |||
| Day Typical Price | 199.77 | |||
| Market Facilitation Index | 3.0E-4 | |||
| Price Action Indicator | (24.10) | |||
| Period Momentum Indicator | (33.90) |
Lineage Cell Forecast Models
Lineage Cell's time-series forecasting models are one of many Lineage Cell's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lineage Cell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Lineage Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Lineage Cell prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lineage shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lineage Cell. By using and applying Lineage Stock analysis, traders can create a robust methodology for identifying Lineage entry and exit points for their positions.
BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California. BIOTIME INC operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 76 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Lineage Cell to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Complementary Tools for Lineage Stock analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |